amantadine has been researched along with Muscular Weakness in 1 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a 48-year-old woman with a 17-year history of PD who developed a peripheral sensory-motor neuropathy secondary to chronic administration (8 years) of amantadine." | 1.30 | Amantadine-induced peripheral neuropathy. ( Minagar, A; Sharma, K; Shulman, LM; Weiner, WJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shulman, LM | 1 |
| Minagar, A | 1 |
| Sharma, K | 1 |
| Weiner, WJ | 1 |
1 other study available for amantadine and Muscular Weakness
| Article | Year |
|---|---|
Amantadine-induced peripheral neuropathy.
Topics: Amantadine; Antiparkinson Agents; Chronic Disease; Female; Humans; Leg; Middle Aged; Muscle Weakness | 1999 |